1 / 3

NCI Alliance for Nanotechnology in Cancer Status Report

Anna D. Barker, Ph.D. and Piotr Grodzinski, Ph.D. Board of Scientific Advisors June 23, 2008. NCI Alliance for Nanotechnology in Cancer Status Report. NCI Approach: Alliance for Nanotechnology in Cancer.

erica-nolan
Télécharger la présentation

NCI Alliance for Nanotechnology in Cancer Status Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Anna D. Barker, Ph.D. and Piotr Grodzinski, Ph.D. Board of Scientific Advisors June 23, 2008 NCI Alliance for Nanotechnology in Cancer Status Report

  2. NCI Approach:Alliance for Nanotechnology in Cancer Medical applications of nanotechnology require multi-disciplinary approach involving both technology developers and technology users in the process of innovation and product development A comprehensive, systematized initiative encompassing the public and private sectors and designed to accelerate the use of the best capabilities of nanotechnology to cancer applications was launched by NCI in 2005 • Centers of Cancer Nanotechnology Excellence (CCNEs) • Cancer Nanotechnology Platform Partnerships (CNPPs) • Training programs • Nanotechnology Characterization Laboratory (NCL)

  3. Major Accomplishments • Scientific standing – 475 journal papers published with average impact factor > 8. • Clinical translation – over 30 companies formed and associated with the program in the space of diagnostics and therapy. Developing strong intellectual property portfolio - 133 disclosures and patents filed. • Leveraged funding: • over $80 M of new, peer-reviewed government research funds (accumulative amount for period of next five years) • over $150 M of funds from philanthropic sources to establish infrastructure and perform research

More Related